{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:20:32Z","timestamp":1787750432633,"version":"build-2784847793"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    Coronary artery lesions are either de novo lesions, where the arterial lumen is narrowed for the first time, or in-stent restenosis, where re-narrowing of a previously stented arterial segment occurs. Sirolimus-coated balloons (SCBs) and paclitaxel-coated balloons (PCBs) are drug-coated balloons used in percutaneous coronary interventions to prevent restenosis without leaving a permanent implant. We conducted a systematic review and meta-analysis comparing SCBs versus PCBs for the treatment of coronary artery lesions, including de novo lesions and in-stent restenosis. Major databases were searched through September 2025. Pooled analyses were performed using random-effects models to calculate risk ratios (RRs) with 95% confidence intervals (CIs). Ten studies involving 5246 patients (SCBs: n = 2964; PCBs: n = 2282) were included. Safety outcomes showed no significant differences in all-cause mortality (RR: 1.39, 95% CI, 0.50\u20133.89,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.53), cardiac death (RR: 1.21, 95% CI, 0.50\u20132.92,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.67), or myocardial infarction (RR: 0.98, 95% CI, 0.59\u20131.64,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.95). Efficacy outcomes were similarly equivalent for target lesion failure (RR: 1.13, 95% CI, 0.85\u20131.50,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.39), target lesion revascularization (RR: 1.23, 95% CI, 0.98\u20131.55,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.068), major adverse cardiac events (RR: 1.14, 95% CI, 0.91\u20131.43,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.27), and binary restenosis (RR: 1.18, 95% CI, 0.63\u20132.20,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.61). None of the interventions (SCBs or PCBs) demonstrated superiority in terms of efficacy or safety for the treatment of coronary artery lesions. Therefore, device selection should be guided by lesion characteristics and overall clinical context.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000001297","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:01:50Z","timestamp":1782133310000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Sirolimus-Coated Versus Paclitaxel-Coated Balloons in the Treatment of Coronary Artery Lesions: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","author":[{"given":"Ahmed Wael","family":"Moftah","sequence":"first","affiliation":[{"name":"Faculty of Medicine, King Salman International University, South Sinai, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Adel","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Zagazig University, Zagazig, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa A.","family":"Solah","sequence":"additional","affiliation":[{"name":"Menoufia University, Faculty of Medicine, Menoufia, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Mohamed","family":"Lasheen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuqa","family":"Al Freijat","sequence":"additional","affiliation":[{"name":"University of Jordan, Faculty of Medicine, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Fouad","family":"Abdrabo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Salah","sequence":"additional","affiliation":[{"name":"South Valley University, Faculty of Medicine, Qena, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul","family":"Abusalah","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, An-Najah National University, Nablus, Palestine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Mahmood","family":"Al-Azzawi","sequence":"additional","affiliation":[{"name":"Liv Hospital Ulus, Faculty of Pharmacy, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Ghawanmeh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan university of science and technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hegazy","sequence":"additional","affiliation":[{"name":"Medway NHS Foundation Trust, Internal Medicine, Gillingham, United Kingdom of Great Britain & Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Fawzi","family":"Hemida","sequence":"additional","affiliation":[{"name":"Alexandria Main University Hospital, Alexandria, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"R1-20260624","doi-asserted-by":"crossref","first-page":"130","DOI":"10.14740\/cr2026","article-title":"Safety and performance of the MOZEC sirolimus-eluting coronary balloon in the treatment of stenotic coronary artery lesions: a real-world, multicenter, post-marketing surveillance study.","volume":"16","author":"Premchand Jain","year":"2025","journal-title":"Cardiol Res"},{"key":"R2-20260624","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis.","volume":"1","author":"Gruntzig","year":"1978","journal-title":"Lancet"},{"key":"R3-20260624","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","article-title":"Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review.","volume":"11","author":"Ralapanawa","year":"2021","journal-title":"J Epidemiol Glob Health"},{"key":"R4-20260624","doi-asserted-by":"crossref","first-page":"1316580","DOI":"10.3389\/fcvm.2024.1316580","article-title":"Treatment of coronary lesions with a novel crystalline sirolimus-coated balloon.","volume":"11","author":"Madanchi","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R5-20260624","first-page":"100625","article-title":"Coronary drug-coated balloons for de novo and in-stent restenosis indications.","volume":"2","author":"Giacoppo","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"R6-20260624","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international dcb consensus group.","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R7-20260624","doi-asserted-by":"crossref","first-page":"906","DOI":"10.5603\/CJ.a2022.0106","article-title":"Metal-free percutaneous coronary interventions in all-comers: first experience with a novel sirolimus-coated balloon.","volume":"29","author":"Madanchi","year":"2022","journal-title":"Cardiol J"},{"key":"R8-20260624","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1526602820942878","article-title":"Commentary: leave nothing behind: no stent, no restenosis, no mortality.","volume":"27","author":"Purushottam","year":"2020","journal-title":"J Endovasc Ther"},{"key":"R9-20260624","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.4244\/EIJ-E-23-00052","article-title":"Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation.","volume":"20","author":"Joner","year":"2024","journal-title":"EuroIntervention"},{"key":"R10-20260624","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial.","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"R11-20260624","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.jcin.2023.11.010","article-title":"Sirolimus-coated balloon angioplasty for coronary artery disease: one step forward, two steps back.","volume":"16","author":"Byrne","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-20260624","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.4244\/EIJ-D-24-00742","article-title":"Sirolimus-coated versus paclitaxel-coated balloons for bifurcated coronary lesions in the side branch: the SPACIOUS trial.","volume":"21","author":"Zhou","year":"2025","journal-title":"EuroIntervention"},{"key":"R13-20260624","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.4244\/EIJ-D-23-00868","article-title":"A randomised trial of sirolimus versus paclitaxel-coated balloons for de novo coronary lesions.","volume":"20","author":"Scheller","year":"2024","journal-title":"EuroIntervention"},{"key":"R14-20260624","doi-asserted-by":"crossref","first-page":"15","DOI":"10.17925\/HI.2019.13.1.15","article-title":"What are the pathological concerns and limitations of current drug-coated balloon technology?","volume":"13","author":"Sato","year":"2019","journal-title":"Heart Int"},{"key":"R15-20260624","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R16-20260624","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","article-title":"PROSPERO: an international register of systematic review protocols.","volume":"38","author":"Schiavo","year":"2019","journal-title":"Med Ref Serv Q"},{"key":"R17-20260624","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2013 a web and mobile app for systematic reviews.","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"R19-20260624","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R20-20260624","year":"2024","journal-title":"R: A language and environment for statistical computing"},{"key":"R21-20260624","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt A","key":"R23-20260624","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited.","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"R24-20260624","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R25-20260624","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjcard.2025.07.004","article-title":"Sirolimus-versus paclitaxel-coated balloons for treatment of coronary artery disease.","volume":"255","author":"Leone","year":"2025","journal-title":"Am J Cardiol"},{"key":"R26-20260624","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcin.2024.12.024","article-title":"Sirolimus- vs paclitaxel-coated balloon for the treatment of coronary in-stent restenosis: the SIBLINT-ISR randomized trial.","volume":"18","author":"Liu","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"R27-20260624","first-page":"e014677","article-title":"Comparing the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the treatment of coronary in-stent restenosis: a prospective randomized study (TIS 2 study).","volume":"18","author":"Pleva","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"R28-20260624","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ihj.2025.03.003","article-title":"Drug-coated balloon in patients with in-stent restenosis: a prospective observational study.","volume":"77","author":"Ray","year":"2025","journal-title":"Indian Heart J"},{"key":"R29-20260624","first-page":"625","article-title":"Comparison of sirolimus-versus paclitaxel-coated balloons in coronary artery disease: one-year results of two real-world prospective registries.","volume":"106","author":"Vlieger","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"R30-20260624","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","article-title":"A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in de novo small vessels.","volume":"16","author":"Ninomiya","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"R31-20260624","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","article-title":"Treatment of coronary de novo lesions by a sirolimus- or paclitaxel-coated balloon.","volume":"15","author":"Ahmad","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"R32-20260624","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23736\/S0031-0808.21.04573-0","article-title":"Paclitexel versus sirolimus-coated balloon in the treatment of coronary instent restenosis.","volume":"65","author":"Briguori","year":"2023","journal-title":"Panminerva Med"},{"key":"R33-20260624","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon.","volume":"12","author":"Ali","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R34-20260624","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/life16010063","article-title":"Paclitaxel- and sirolimus-coated balloons versus drug-eluting stents in coronary artery disease: a comprehensive narrative review.","volume":"16","author":"Gherasie","year":"2025","journal-title":"Life"},{"key":"R35-20260624","doi-asserted-by":"crossref","first-page":"e013302","DOI":"10.1161\/CIRCINTERVENTIONS.123.013302","article-title":"Drug-coated balloons in the management of coronary artery disease.","volume":"17","author":"Korjian","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"R36-20260624","first-page":"86","article-title":"Drug-coated balloons in percutaneous coronary interventions: insights into device design and translation to the clinic.","volume":"13","author":"Tanaka","year":"2025","journal-title":"EMJ Int Cardiol"},{"key":"R37-20260624","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5603\/cj.101393","article-title":"Drug-coated balloons in percutaneous coronary interventions: existing evidence and emerging hopes.","volume":"32","author":"G\u0105secka","year":"2025","journal-title":"Cardiol J"},{"key":"R38-20260624","first-page":"425","article-title":"Paclitaxel-coated versus sirolimus-coated balloon angioplasty for coronary artery disease: a systematic review and meta-analysis.","volume":"104","author":"Shin","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"R39-20260624","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carrev.2021.04.013","article-title":"Comparison between sirolimus- and paclitaxel-coated balloon for revascularization of coronary arteries: the SIRPAC (SIRolimus-PAClitaxel) study.","volume":"28","author":"Cortese","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"R40-20260624","doi-asserted-by":"crossref","first-page":"111468","DOI":"10.4330\/wjc.v17.i12.111468","article-title":"Coronary drug-coated balloons: current evidence and emerging trends.","volume":"17","author":"Bhandari","year":"2025","journal-title":"World J Cardiol"},{"key":"R41-20260624","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jcin.2024.04.042","article-title":"Outcomes with limus- vs paclitaxel-coated balloons for percutaneous coronary intervention: meta-analysis of randomized controlled trials.","volume":"17","author":"Sedhom","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"R42-20260624","first-page":"194","article-title":"Drug-coated balloons: recent evidence and upcoming novelties.","volume":"12","author":"Shahrori","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"R43-20260624","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tcm.2024.08.006","article-title":"Coronary drug-coated balloons: a comprehensive review of clinical applications and controversies.","volume":"35","author":"Khawaja","year":"2025","journal-title":"Trends Cardiovasc Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:33:44Z","timestamp":1787747624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001297","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}